Discontinuation report DIABETA

Last updated on 2020-08-04 History
Report ID 100935
Drug Identification Number 02224550
Brand name DIABETA
Common or Proper name Diabeta
Company Name SANOFI-AVENTIS CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) GLYBURIDE
Strength(s) 2.5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30
ATC code A10BB
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2020-02-28
Actual discontinuation date 2020-05-07
Remaining supply date 2020-02-28
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments Last lot 8116831 expiry 2020-08-27
Health Canada comments
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-08-04 French Compare
v3 2020-08-04 English Compare
v2 2019-12-11 French Compare
v1 2019-12-11 English Compare